Have you come across Dr. Mark Skousen’s recent presentation regarding the proclaimed, “Swiss Army Bio-Knife?” Shared by the Eagle Financial Publications, it has been revealed that this is Dr. Mark Skousen’s next predicted investment opportunity that cannot go missed. Here’s what you need to know:
Contents
What is the Swiss Army Bio-Knife?
Swiss Army Bio-Knife was supposedly created by a 24-year-old company hidden in the mountains of Switzerland. Operating within the medical industry, this respective firm is deemed a “diamond” because of a cure they’ve developed for conditions such as cancer, and Alzheimer’s and heart disease to name a few.
Why invest in the Swiss Army Bio-Knife?
So which disease in particular is this firm attempting to cure? It turns out it is none other than Rheumatoid Arthritis, which is an autoimmune disease experienced in the later stages of life, primarily 30 and plus. While the first ever drug to treat this condition was launched in 1947, called methotrexate, it is said to destroy both good and bad cells.
This is where Swiss Army Bio-Knife’s solution called the Raptor, comes into play, as it does the healing without any added damages. Raptor was supposedly created in partnership with a company called, American X (which is not the real name), where the latter has exclusive commercial rights to the products.
So, where does the investment opportunity rest? It’s in this unknown firm referred to as American X. Dr. Mark Skousen is confident in this specific investment because of the former’s ability to fund said research projects and the fact that they so far house over 40 FDA-approved products with others in the work-in-progress stages.
What is Dr. Mark Skousen’s offer?
Given his research and how far American X has come, Dr. Mark Skousen trusts this is THE stock for 2020. Wouldn’t it be great to know which firm this is? Here are the reports in which such information will be disclosed:
American X Unmasked: The Biotech Behemoth With $52 Billion in Annual Sales
Investors will come to learn about the Swiss firm that started this respective solution along with the revelation of American X. In addition, investors will also be offered his “Forecasts & Strategies” model portfolio, his current buys including growth and income stocks, other sources of revenue (i.e. gold, natural resource stocks, energy stocks, etc.), and a breakdown on interest rates among others.
Access to other reports written by Dr. Mark Skousen include:
The Age of Artificial Intelligence and the Multi-Millionaires it Will Create
Dr. Mark Skousen’s 5 Favorite High-Income Growth Stocks, specifically, real estate properties, hospitals, clinics, and laboratories among others.
The Next Healthcare Powerhouse, focusing on neurodegenerative diseases
Additionally, he will be offering several bonuses, which he deems are essential in making profits. Here’s a brief overview:
Bonus 1: Get a Year’s Worth of Profits in Just 5 Minutes discloses five stocks that have wrecked that of well-established firms
Bonus 2: Live Long & Prosper with Dr. Mark Skousen’s #1 Biotech Pick expounds on a firm that has recently developed a heart-imaging technology that records one’s heart in real time
How much does Dr. Mark Skousen’s Swiss Army Bio-Knife cost?
Upon subscribing to Dr. Mark Skousen’s reports, the first year is said to cost $49.95. The reason why he claims to offer his report at a lower rate f is because he wants investors to have a feel of the type of information he produces and to assess whether they match their investment goals. In addition, he will be offering a 30-day, risk-free, all-your-money-back guarantee should the expert’s approach not match that of investors.
Recap
Dr. Mark Skousen’s recent discovery is believed to be one of THE stocks to revolutionize the financial market in 2020, as the firm he’s in support of has potentially found the next best solution that could treat Rheumatoid Arthritis. The company, which will remain unknown until investors subscribe to his service, has supposedly been able to generate billions in revenue. Hence, possibly helping investors make the most out of their own money.
At a price of $49, investors are granted access to a wide range of information regarding the current stance of several, unique industry players. Therefore, there appears to be a lot of investment opportunities presented within the Swiss Army Bio-Knife.
On that note, here are some clarifications regarding this service:
Who is Dr. Mark Skousen?
Dr. Mark Skousen is the editor of Forecasts & Strategies, Home Run Trader, Fast Money Alert, Five Star Trader and TNT Trader. Furthermore, he is also part of the Eagle Financial Publications group of financial investment advisors. Besides his role as an editor, he is also a nationally known investment expert who has since written well over 25 books. Serving as the President Fellow at Chapman University, he was recently awarded the Triple Crown in Economics for his devotion to the field of economics.
Should I have a question regarding the Swiss Army Bio-Knife, how can I get in touch?
If a question is not answered under the Frequently Asked Questions section, then investors have been advised to contact the customer service department at CustomerService@MarkSkousen.com or call 1-800-211-7661.
How does one get access to the Swiss Army Bio-Knife and its reports?
Upon subscribing, instant access to download the reports will be provided. An email will also be sent out for those who’d like to have access to the reports anytime anywhere. On each r account, information regarding the subscription’s expiry date, and the process to renew should one still require said service will be available. It is also important to note that the email might fall in the SPAM folder, so this is something to be on the lookout for.
To gain access to Dr. Mark Skousen’s 30-day test drive, visit his official website.
